Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

One out of the three major indices are trading up today with the

Dow Jones Industrial Average

(

^DJI

) trading up 11 points (0.1%) at 17,997 as of Friday, Feb. 20, 2015, 12:10 PM ET. The NYSE advances/declines ratio sits at 1,566 issues advancing vs. 1,413 declining with 145 unchanged.

The Health Services industry currently sits down 0.2% versus the S&P 500, which is down 0.1%. On the negative front, top decliners within the industry include

Grifols

(

GRFS

), down 1.6%,

Baxter International

(

BAX

), down 1.2% and

Boston Scientific

(

BSX

), down 0.7%. Top gainers within the industry include

AMN Healthcare Services

(

AHS

), up 14.3%,

Humana

(

HUM

), up 1.6%,

Agilent Technologies

(

A

), up 1.4%,

Catamaran

(

CTRX

), up 1.1% and

Cigna

(

CI

), up 0.8%.

TheStreet would like to highlight 3 stocks pushing the industry lower today:

3.

Bruker

(

BRKR

) is one of the companies pushing the Health Services industry lower today. As of noon trading, Bruker is down $0.72 (-3.7%) to $18.65 on heavy volume. Thus far, 712,803 shares of Bruker exchanged hands as compared to its average daily volume of 786,100 shares. The stock has ranged in price between $18.32-$19.45 after having opened the day at $18.58 as compared to the previous trading day's close of $19.37.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Bruker Corporation, together with its subsidiaries, designs, manufactures, sells, and services proprietary life science and materials research systems, and associated products worldwide. It operates through two segments, Scientific Instruments, and Energy & Supercon Technologies. Bruker has a market cap of $3.2 billion and is part of the health care sector. Shares are down 1.3% year-to-date as of the close of trading on Thursday. Currently there are 3 analysts that rate Bruker a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates

Bruker

as a

hold

. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, expanding profit margins and notable return on equity. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, unimpressive growth in net income and weak operating cash flow. Get the full

Bruker Ratings Report

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading,

Smith & Nephew

(

SNN

) is down $0.36 (-1.0%) to $36.16 on light volume. Thus far, 81,424 shares of Smith & Nephew exchanged hands as compared to its average daily volume of 705,600 shares. The stock has ranged in price between $36.01-$36.22 after having opened the day at $36.10 as compared to the previous trading day's close of $36.52.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Smith & Nephew plc develops, manufactures, markets, and sells medical devices in the advanced surgical devices and advanced wound management sectors worldwide. Smith & Nephew has a market cap of $16.4 billion and is part of the health care sector. Shares are down 0.6% year-to-date as of the close of trading on Thursday. Currently there are 2 analysts that rate Smith & Nephew a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates

Smith & Nephew

as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full

Smith & Nephew Ratings Report

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading,

Intuitive Surgical

(

ISRG

) is down $3.81 (-0.7%) to $507.66 on light volume. Thus far, 76,460 shares of Intuitive Surgical exchanged hands as compared to its average daily volume of 242,200 shares. The stock has ranged in price between $506.28-$511.25 after having opened the day at $511.25 as compared to the previous trading day's close of $511.47.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Intuitive Surgical has a market cap of $18.8 billion and is part of the health care sector. Shares are down 3.3% year-to-date as of the close of trading on Thursday. Currently there are 10 analysts that rate Intuitive Surgical a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates

Intuitive Surgical

as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full

Intuitive Surgical Ratings Report

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health services industry could consider

ProShares Ultra Short Health Care

(

RXD

).

null